Fondaparinux: Clinical Trials

8 trials of Fondaparinux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown, 1 withdrawn. 8 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Terminated 1, Unknown 1, Withdrawn 1
Phase 32Completed 1, Unknown 1

Follow Fondaparinux: new trials by email Literature Review of Fondaparinux trials Research Report on Fondaparinux

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
Tirofiban Injection, Clopidogrel, Acetylsalicylic acid - Pneumonia, Viral, Corona Virus Infection
Phase 2CompletedUniversity of Milan52020-04-062020-04-29
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
fondaparinux, unfractionated heparin, Vitamin-K-Antagonist - Fibrillation, Atrial
Phase 2CompletedGlaxoSmithKline3492009-08-012012-10-01
Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures
Nadroparin, Fondaparinux - Deep Vein Thrombosis, Pulmonary Embolism
Phase 2 / Phase 3UnknownRed Cross Hospital Beverwijk6692009-04-012012-12-18
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
fondaparinux sodium, sequential compression devices - Venous Thromboembolism
Phase 2 / Phase 3CompletedMary Knudson, M.D.1052007-12-012013-12-24
Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
fondaparinux, warfarin - Heparin-Induced Thrombocytopenia
Phase 2TerminatedUniversity of Louisville32007-11-012019-11-08
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
Fondaparinux Sodium - Venous Thrombosis, Pulmonary Embolism
Phase 2CompletedUniversity of Pittsburgh212007-02-012008-05-16
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
fondaparinux sodium - Cervical Cancer, Endometrial Cancer
Phase 2CompletedMasonic Cancer Center, University of Minnesota442007-01-012017-12-28
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
fondaparinux sodium, heparin, percutaneous coronary intervention (PCI) - Myocardial Infarction, Coronary Disease
Phase 2WithdrawnSchering-Plough3002003-04-012009-11-03

Conditions studied

Pulmonary Embolism (3)  ·  Venous Thrombosis (3)  ·  Thrombosis (2)  ·  Acute Coronary Syndrome (1)  ·  Ankle Fractures (1)  ·  Arrhythmias, Cardiac (1)  ·  Atrial Fibrillation (1)  ·  COVID-19 (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Coronavirus Infections (1)  ·  Embolism and Thrombosis (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)

Sponsors

GlaxoSmithKline (1)  ·  Mary Knudson, M.D. (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Red Cross Hospital Beverwijk (1)  ·  Schering-Plough (1)  ·  University of Louisville (1)  ·  University of Milan (1)  ·  University of Pittsburgh (1)

Countries

United States (5)  ·  France (2)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Goetz H Kloecker, MD, MSPH (1)  ·  Ioannis Raftopoulos, MD, PhD (1)  ·  Levi S. Downs, MD (1)  ·  M. Margaret Knudson, MD (1)  ·  Roelf S Breederveld, MD, PhD (1)  ·  Yannick M Groutars, MD (1)

Results publications

PMID 19854398, PMID 28279428, PMID 33502773, PMID 35244208